Nucleai
Alexander Lazar MD/PhD is a prominent academic and medical professional with extensive experience in pathology and genomic medicine. Currently serving as a Professor of Pathology, Genomic Medicine, Translational Molecular Pathology, and Dermatology at MD Anderson Cancer Center, Alexander also directs multiple fellowship training programs focused on sarcoma and melanoma. In addition to academic roles at UT Graduate School of Biomedical Sciences at Houston, Alexander is a partner at Gothams and managing partner at Technoscience, while contributing as a strategic mentor at Creative Destruction Lab. Notably, Alexander has held significant positions during the COVID-19 pandemic, including as a member of the Governor's COVID Strike Force in Texas and Biosecurity Director for the 59th US Inaugural Ceremonies. Alexander's clinical training includes a fellowship in Dermatopathology at Massachusetts General Hospital and a Clinical Fellowship at Harvard Medical School. Educational background includes an MD and PhD from UT Southwestern Medical Center, following a BA from Austin College.
This person is not in the org chart
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.